glp 1 neurotransmitter Glucagon-like peptide-1 (GLP-1), released from the intestine, informs GLP-1 Receptor Agonists in Neurodegeneration:

At first, rubber stoppers are fitted on the necks of vials and then aluminum crimp seals are oriented over stoppers and crimped around vial necks by use of the crimping tool

Injectable GLP-1s currently have the most established weight loss evidence base, with tirzepatide showing the largest reductions in head-to-head trials, but oral options have closed much of the gap

the GLP-1 activity changed little but slight decreases were observed in the GIP activity

PMID: 29688261 Bahri Khomami M, et al

Consider booking a complimentary discovery call with me so we can chat about your health goals and see if we are a good fit to work together